top of page

Tisotumab Vedotin: Adverse Events and Management ~ 8/2/22 @6pm

Updated: Jul 27, 2022

Join us Tuesday August 2nd @ 6:00 pm

Abe & Louie's

793 Boylston St, Boston, MA 02116

Presentation: - Tisotumab Vedotin MOA - FDA approved indication -

Common adverse events and management

Thank you for your interest in attending this education program requested by Boston ONS. The presentation will be provided by the New England Genmab Medical Science Liaison on behalf of Genmab Medical Affairs.

There are 33 slots available for this program and RSVP will secure your participation on a first-come-first-serve basis.

Please RSVP by emailing at your earliest convenience, including your place of practice and current professional role/credentials. Sign in will be required upon arrival.

Please circulate this invitation as you see fit keeping in mind that this program is intended for nurses, advanced practitioners, pharmacists, and physicians.

Look forward to meeting you! Arielle Arielle Bibeault, PharmD, BCPS, BCOP Senior Medical Science Liaison – New England Based in

Boston Work Cell 609 613 2963

Personal Cell 401-323-8482

Genmab US, Inc.

777 Scudders Mill Road, Bldg. 2, 4th Floor,

Plainsboro, NJ 08536, US

94 views0 comments


bottom of page